Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had revenue of $494.00K in the quarter ending March 31, 2026, with 31.73% growth. This brings the company's revenue in the last twelve months to $1.50M, up 1.63% year-over-year. In the year 2025, Northwest Biotherapeutics had annual revenue of $1.38M, down -0.29%.

• Revenue (ttm): 1.50M
• Revenue Growth: +1.63%
• P/S Ratio: 226.00
• Revenue / Employee: 14.26K
• Employees: 105
• Market Cap: 338.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.38M	-4.00K	-0.29%
Dec 31, 2024	1.38M	-550.00K	-28.47%
Dec 31, 2023	1.93M	249.00K	14.80%
Dec 31, 2022	1.68M	678.00K	67.46%
Dec 31, 2021	1.01M	-286.00K	-22.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error